In obesity, plasma FFAs are chronically elevated [65], which in muscle, can directly inhibit insulin activation of the IRS-1/PI3K/Akt pathway leading to reduced glucose uptake and phosphorylation, and decreased glycogen synthase activity [66,67]. The gene discussed is INS; the disease is Obesity.